Literature DB >> 2836863

Structural organization of the human alpha-galactosidase A gene: further evidence for the absence of a 3' untranslated region.

D F Bishop1, R Kornreich, R J Desnick.   

Abstract

Human alpha-galactosidase A (alpha-D-galactoside galactohydrolase; EC 3.2.1.22) is a lysosomal hydrolase encoded by a gene localized to the chromosomal region Xq22. The deficient activity of this enzyme results in Fabry disease, an X chromosome-linked recessive disorder that leads to premature death in affected males. For studies of the structure and function of alpha-galactosidase A and for characterization of the genetic lesions in families with Fabry disease, the full-length cDNA was isolated, sequenced, and used to screen human genomic libraries. The 1393-base-pair full-length cDNA had a 60-nucleotide 5' untranslated region and encoded a precursor peptide of 429 amino acids including a signal peptide of 31 residues. Three overlapping lambda clones spanning 32 kilobases were identified that contained the entire approximately equal to 12-kilobase chromosomal gene as well as approximately equal to 9 and approximately equal to 11 kilobases of 5' and 3' flanking sequence, respectively. The gene had seven exons. The genomic exonic and full-length cDNA sequences were identical. All intron-exon splice junctions conformed to the GT/AT consensus sequence. The 5' flanking region of this lysosomal housekeeping gene contained Sp1 and CCAAT box promoter elements as well as sequences corresponding to the activator protein 1 (AP1), octanucleotide ("OCTA"), and "core" enhancer elements. There was an upstream "HTF" island (Hpa II tiny fragments) followed by four direct repeats of the "chorion box" enhancer. The unique lack of a 3' untranslated sequence in the alpha-galactosidase A cDNA was confirmed by sequencing additional cDNA clones and the genomic 3' region.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2836863      PMCID: PMC280328          DOI: 10.1073/pnas.85.11.3903

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  58 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Purification and properties of the two major isozymes of alpha-galactosidase from human placenta.

Authors:  J W Kusiak; J M Quirk; R O Brady
Journal:  J Biol Chem       Date:  1978-01-10       Impact factor: 5.157

3.  Active X chromosome DNA is unmethylated at eight CCGG sites clustered in a guanine-plus-cytosine-rich island at the 5' end of the gene for phosphoglycerate kinase.

Authors:  D H Keith; J Singer-Sam; A D Riggs
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

4.  Screening lambdagt recombinant clones by hybridization to single plaques in situ.

Authors:  W D Benton; R W Davis
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

5.  Absence of cross-reactive antigen in Fabry's disease.

Authors:  E Beutler; W Kuhl
Journal:  N Engl J Med       Date:  1973-09-27       Impact factor: 91.245

6.  Ceramide trihexosidosis (fabry's disease) without skin lesions.

Authors:  J T Clarke; J Knaack; J C Crawhall; L S Wolfe
Journal:  N Engl J Med       Date:  1971-02-04       Impact factor: 91.245

7.  Charon phages: safer derivatives of bacteriophage lambda for DNA cloning.

Authors:  F R Blattner; B G Williams; A E Blechl; K Denniston-Thompson; H E Faber; L Furlong; D J Grunwald; D O Kiefer; D D Moore; J W Schumm; E L Sheldon; O Smithies
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

8.  Residual activity of alpha-galactosidase A in Fabry's disease.

Authors:  G Romeo; M D'Urso; A Pisacane; E Blum; A De Falco; A Ruffilli
Journal:  Biochem Genet       Date:  1975-10       Impact factor: 1.890

9.  alpha-galactosidase A from human placenta. Stability and subunit size.

Authors:  J S Mayes; E Beutler
Journal:  Biochim Biophys Acta       Date:  1977-10-13

10.  Investigation of the alpha-galactosidase deficiency in Fabry's disease using antibodies against the purified enzyme.

Authors:  P J Rietra; J L Molenaar; M N Hamers; J M Tager; P Borst
Journal:  Eur J Biochem       Date:  1974-07-01
View more
  38 in total

1.  Point mutations in the upstream region of the alpha-galactosidase A gene exon 6 in an atypical variant of Fabry disease.

Authors:  S Ishii; H Sakuraba; Y Suzuki
Journal:  Hum Genet       Date:  1992-04       Impact factor: 4.132

2.  Characterization of the human lysosomal alpha-glucosidase gene.

Authors:  L H Hoefsloot; M Hoogeveen-Westerveld; A J Reuser; B A Oostra
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

3.  Fabry disease in a large Nova Scotia kindred: carrier detection using leucocyte alpha-galactosidase activity and an NcoI polymorphism detected by an alpha-galactosidase cDNA clone.

Authors:  A J Kirkilionis; D C Riddell; M W Spence; R G Fenwick
Journal:  J Med Genet       Date:  1991-04       Impact factor: 6.318

Review 4.  3' end mRNA processing: molecular mechanisms and implications for health and disease.

Authors:  Sven Danckwardt; Matthias W Hentze; Andreas E Kulozik
Journal:  EMBO J       Date:  2008-02-06       Impact factor: 11.598

5.  Prediction of response of mutated alpha-galactosidase A to a pharmacological chaperone.

Authors:  Sang H Shin; Stefanie Kluepfel-Stahl; Adele M Cooney; Christine R Kaneski; Jane M Quirk; Raphael Schiffmann; Roscoe O Brady; Gary J Murray
Journal:  Pharmacogenet Genomics       Date:  2008-09       Impact factor: 2.089

6.  Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes.

Authors:  C Whybra; C Kampmann; I Willers; J Davies; B Winchester; J Kriegsmann; K Brühl; A Gal; S Bunge; M Beck
Journal:  J Inherit Metab Dis       Date:  2001-12       Impact factor: 4.982

Review 7.  RNA surveillance: molecular approaches in transcript quality control and their implications in clinical diseases.

Authors:  Karen C M Moraes
Journal:  Mol Med       Date:  2009-10-07       Impact factor: 6.354

8.  Novel trinucleotide deletion in Fabry's disease.

Authors:  M A Cariolou; M Christodoulides; P Manoli; A Kokkofitou; D Tsambaos
Journal:  Hum Genet       Date:  1996-04       Impact factor: 4.132

9.  Uneven X inactivation in a female monozygotic twin pair with Fabry disease and discordant expression of a novel mutation in the alpha-galactosidase A gene.

Authors:  I Redonnet-Vernhet; J K Ploos van Amstel; R P Jansen; R A Wevers; R Salvayre; T Levade
Journal:  J Med Genet       Date:  1996-08       Impact factor: 6.318

Review 10.  Implications of polyadenylation in health and disease.

Authors:  Ana Curinha; Sandra Oliveira Braz; Isabel Pereira-Castro; Andrea Cruz; Alexandra Moreira
Journal:  Nucleus       Date:  2014-10-31       Impact factor: 4.197

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.